** Brokerage BMO Capital Markets raises price target on agrichemicals company Corteva CTVA.N to $86 from $74
** The new price target represents a nearly 10% upside to the stock's last close
** "We think the stock can continue to work as current attractive multiples keep getting rolled forward on a strong growth profile," - BMO says
** Brokerage adds CTVA can push over $90/shr if the company hits its 2027 EBITDA guidance range midpoint of $4.4 billion
** Shares of CTVA marginally down at $76.35 premarket
** 18 of 25 brokerages rate the stock "buy" or higher, and seven rate it "hold"; their median PT is $75.50 - LSEG Data
** As of last close, CTVA stock is up over 34% YTD
(Reporting by Vallari Srivastava in Bengaluru)
((Srivastava.Vallari@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.